No Adverse Impact of Obesity in Biologic-Treated IBD

People with inflammatory bowel disease and obesity can be safely started on biologic therapies, suggests an analysis of over 3000 patients.
Medscape Medical News

source https://www.medscape.com/viewarticle/976532?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost